Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country symbols : Mnmd save search
MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120
Published: 2024-03-01 (Crawled : 15:00) - biospace.com/
MNMD | $8.7 -2.36% -2.41% 1.5M
|
n/a
|
| O: 0.96%
H: 8.67%
C: 7.97%
mm120 conference update
MindMed Announces Business Update and Anticipated Milestones for 2024
Published: 2024-01-08 (Crawled : 14:00) - biospace.com/
MNMD | $8.7 -2.36% -2.41% 1.5M
|
n/a
|
| O: 0.98%
H: 7.51%
C: 6.3%
business update
MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference
Published: 2022-10-05 (Crawled : 16:00) - biospace.com/
MNMD | $8.7 -2.36% -2.41% 1.5M
|
n/a
|
| O: -1.14%
H: 2.31%
C: 1.73%
conference
MindMed to Participate in the Canaccord Genuity 42nd Annual Growth Conference
Published: 2022-08-02 (Crawled : 12:20) - biospace.com/
MNMD | $8.7 -2.36% -2.41% 1.5M
|
n/a
|
| O: 0.74%
H: 5.2%
C: 3.46%
conference growth
MindMed Reports Topline Data From Phase 1 Trial of MM-110 in Development for the Treatment of Opioid Withdrawal
Published: 2022-05-19 (Crawled : 20:00) - biospace.com/
MNMD | $8.7 -2.36% -2.41% 1.5M
|
n/a
|
| O: 0.56%
H: 3.52%
C: -0.95%
mm-110 treatment opioid topline trial phase 1
MindMed Collaborators Prof. Liechti and Dr. Holze Announce Positive Topline Data from Phase 2 Trial Evaluating LSD in Anxiety Disorders
Published: 2022-05-11 (Crawled : 14:00) - biospace.com/
MNMD | $8.7 -2.36% -2.41% 1.5M
|
n/a
|
| O: -0.46%
H: 0.0%
C: 0.0%
topline trial positive phase 2 lsd
MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC
Published: 2022-01-04 (Crawled : 20:00) - biospace.com/
MNMD | $8.7 -2.36% -2.41% 1.5M
|
n/a
|
| O: -1.32%
H: 1.33%
C: -1.33%
trial phase 1 phase 2 phase 3
MindMed to Participate at the Benzinga Global Small Cap Conference
Published: 2021-12-02 (Crawled : 13:00) - biospace.com/
MNMD | $8.7 -2.36% -2.41% 1.5M
|
n/a
|
| O: -4.67%
H: 3.09%
C: 2.58%
conference
MindMed to Present at H.C. Wainwright 2nd Annual Psychedelics Conference
Published: 2021-12-01 (Crawled : 13:00) - biospace.com/
MNMD | $8.7 -2.36% -2.41% 1.5M
|
n/a
|
| O: 3.56%
H: 0.0%
C: 0.0%
conference
MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a System for Identifying Agitation Episodes
Published: 2021-09-02 (Crawled : 14:15) - biospace.com/
MNMD | $8.7 -2.36% -2.41% 1.5M
|
n/a
|
| O: 0.0%
H: 3.14%
C: 2.79%
BTAI | $2.77 8.63% 7.94% 620K
|
Health Technology
|
| O: 0.27%
H: 2.58%
C: 1.75%
patent application
MindMed Announces Chief Executive Officer Transition
Published: 2021-06-09 (Crawled : 12:00) - biospace.com/
MNMD | $8.7 -2.36% -2.41% 1.5M
|
n/a
|
| O: -7.01%
H: 6.96%
C: 2.03%
Gainers vs Losers
| 69% | 31% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.